These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8318369)

  • 41. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
    Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Marrow transplantation for pancytopenia in dyskeratosis congenita.
    Mahmoud HK; Schaefer UW; Schmidt CG; Becher R; Götz GF; Richter HJ
    Blut; 1985 Jul; 51(1):57-60. PubMed ID: 3893572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dyskeratosis congenita associated with leukoplakia of the tongue.
    Noto Z; Tomihara K; Furukawa K; Noguchi M
    Int J Oral Maxillofac Surg; 2016 Jun; 45(6):760-3. PubMed ID: 26778687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dyskeratosis congenita with aplastic anemia].
    Benítez-Aranda H; Farfán-Canto J; Velázquez E
    Bol Med Hosp Infant Mex; 1988 Dec; 45(12):846-9. PubMed ID: 3240349
    [No Abstract]   [Full Text] [Related]  

  • 45. Dyskeratosis congenita: hematologic evaluation of a sibship and review of the literature.
    Trowbridge AA; Sirinavin C; Linman JW
    Am J Hematol; 1977; 3():143-52. PubMed ID: 602933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dyskeratosis congenita. Report of a large kindred.
    Connor JM; Teague RH
    Br J Dermatol; 1981 Sep; 105(3):321-5. PubMed ID: 7272212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
    Fogarty PF; Yamaguchi H; Wiestner A; Baerlocher GM; Sloand E; Zeng WS; Read EJ; Lansdorp PM; Young NS
    Lancet; 2003 Nov; 362(9396):1628-30. PubMed ID: 14630445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progressive immune failure in dyskeratosis congenita. Report of an adult in whom Pneumocystis carinii and fatal disseminated candidiasis developed.
    Wiedemann HP; McGuire J; Dwyer JM; Sabetta J; Gee JB; Smith GJ; Loke J
    Arch Intern Med; 1984 Feb; 144(2):397-9. PubMed ID: 6607716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dyskeratosis congenita is a chromosomal instability disorder.
    Dokal I; Luzzatto L
    Leuk Lymphoma; 1994 Sep; 15(1-2):1-7. PubMed ID: 7858487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
    Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW
    BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hoyeraal-Hreidarsson syndrome: magnetic resonance imaging findings.
    Kuwashima S
    Jpn J Radiol; 2009 Oct; 27(8):324-7. PubMed ID: 19856229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita.
    Kanegane H; Kasahara Y; Okamura J; Hongo T; Tanaka R; Nomura K; Kojima S; Miyawaki T
    Br J Haematol; 2005 May; 129(3):432-4. PubMed ID: 15842668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dyskeratosis congenita.
    Davidson HR; Connor JM
    J Med Genet; 1988 Dec; 25(12):843-6. PubMed ID: 3236366
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical heterogeneity in a family with
    Olivieri C; Mondino A; Chinello M; Risso A; Finale E; Lanciotti M; Guala A
    Pediatr Rep; 2017 Oct; 9(3):7301. PubMed ID: 29081935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dyskeratosis congenita associated with elevated fetal hemoglobin, X-linked ocular albinism, and juvenile-onset diabetes mellitus.
    Reichel M; Grix AC; Isseroff RR
    Pediatr Dermatol; 1992 Jun; 9(2):103-6. PubMed ID: 1376473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Focal dermal hypoplasia.
    Ruiz-Maldonado R; Carnevale A; Tamayo L; Milonas de Montiel M
    Clin Genet; 1974; 6(1):36-45. PubMed ID: 4426129
    [No Abstract]   [Full Text] [Related]  

  • 57. A case report on a rare disease: dyskeratosis congenita.
    Shiferaw B; Mukka S; Ha L; Bekele E; Ramos De Oleo R
    J Clin Med Res; 2015 May; 7(5):361-3. PubMed ID: 25780486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis.
    Knight SW; Vulliamy TJ; Heiss NS; Matthijs G; Devriendt K; Connor JM; D'Urso M; Poustka A; Mason PJ; Dokal I
    J Med Genet; 1998 Dec; 35(12):993-6. PubMed ID: 9863595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dyskeratosis congenita: two examples of this multisystem disorder.
    Womer R; Clark JE; Wood P; Sabio H; Kelly TE
    Pediatrics; 1983 Apr; 71(4):603-9. PubMed ID: 6601257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dyskeratosis congenita with macular cutaneous amyloid deposits.
    Llistosella E; Moreno A; de Moragas JM
    Arch Dermatol; 1984 Oct; 120(10):1381-2. PubMed ID: 6486855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.